Critics of gender-affirming care for minors made their case at a day-long workshop before a Federal Trade Commission (FTC) that, under the Trump administration, has warmed to their views.

The FTC has an "unequivocal basis" to investigate the transgender medicine industry, Commissioner Mark Meador says.

Companies that can't back up claims that their products are made in the U.S. could face hefty penalties from the Federal Trade Commission.

A U.S. judge formally admonished Amazon.com on Thursday for withholding documents from the U.S. Federal Trade Commission in a lawsuit accusing the e-commerce giant of deceiving customers of its paid Prime service.

Commission Chair Andrew Ferguson opened the workshop, titled "The Dangers of 'Gender-Affirming Care' for Minors," and in his remarks said that the agency will issue a request for information in the near future on gender-affirming care, emphasizing that the workshop was "not about politics."

Doctors who pitched medical treatments to minors with gender dysphoria may have deceived them, according to the Federal Trade Commission.

The Federal Trade Commission (FTC) was established as an independent administrative agency pursuant to the Federal Trade Commission Act of 1914. The

The daylong invite-only workshop features detransitions, parents, regulators and scientific experts on puberty blockers, cross-sex hormones and surgery for gender-confused youth.